文献速递产科母胎医学

单胎试管婴儿妊娠中的母亲高血糖可能受早孕期体重指数影响

Maternal hyperglycemia in singleton pregnancies conceived by IVF may be modified by first-trimester BMI.
PubMed 文献 · Hum Reprod · 2017-01-01

这项横断面研究纳入1089例单胎妊娠女性(自然受孕1013例,IVF受孕76例),在孕26-28周行75g口服葡萄糖耐量试验。调整常见GDM危险因素后,IVF妊娠的GDM odds接近翻倍(OR=1.83,95%CI 1.03-3.26),空腹及2小时血糖均升高;按早孕期BMI分层后,上述风险仅在超重或肥胖(BMI>25 kg/m2)的IVF组中显著。

要点

  • IVF似乎是GDM和血糖升高的独立危险因素,但该风险仅见于超重或肥胖(BMI>25 kg/m2)女性。
  • 超重或肥胖IVF组GDM的OR=3.54(95%CI 1.44-8.72),空腹血糖平均差0.39 mmol/L(95%CI 0.13-0.65)。
  • 作者建议计划IVF的超重或肥胖女性术前减重,并在不常规筛查GDM的环境中接受筛查。

核心结论

  • IVF似乎是超重女性(BMI>25 kg/m2)发生GDM和血糖升高的独立危险因素。
  • 作者认为应建议计划IVF的超重或肥胖女性在手术前减重,以降低GDM及高血糖相关不良结局风险。
  • 在未常规开展GDM筛查的环境中,经IVF受孕的超重或肥胖女性应接受筛查。

研究设计与样本

  • 横断面研究,使用新加坡出生队列研究(GUSTO)中1089例单胎妊娠女性的数据。
  • 1089例中自然受孕1013例,经IVF受孕76例。
  • 所有研究对象在孕26-28周接受75g口服葡萄糖耐量试验(OGTT),检测空腹和餐后2小时血糖。

主要发现

  • 调整常见GDM危险因素后,IVF妊娠的GDM odds接近翻倍(OR=1.83,95%CI 1.03-3.26)。
  • IVF妊娠空腹血糖平均差为0.12 mmol/L(95%CI 0.00-0.24),OGTT 2小时血糖平均差为0.64 mmol/L(95%CI 0.27-1.01)。
  • 按早孕期BMI分层后,仅在超重或肥胖(BMI>25 kg/m2)的IVF组中GDM风险显著升高(OR=3.54,95%CI 1.44-8.72)。
  • 同一超重或肥胖IVF组中,空腹血糖平均差为0.39 mmol/L(95%CI 0.13-0.65),2小时血糖平均差为1.24 mmol/L(95%CI 0.56-1.91)。

关键数值与推荐

  • 采用世界卫生组织(1999)标准诊断GDM:空腹血浆葡萄糖≥7.0 mmol/L和/或2小时餐后血浆葡萄糖≥7.8 mmol/L,为研究期间使用的临床指南。

临床怎么用

  • 作者建议计划IVF的超重或肥胖女性在手术前减重,以降低GDM和高血糖相关不良结局风险。
  • 作者认为在未常规开展GDM筛查的环境中,经IVF受孕的超重或肥胖女性应接受筛查。

局限性

  • 研究缺少OGTT后1小时血浆葡萄糖样本,因研究期间使用1999年WHO诊断标准(新加坡当时临床指南)而非2013年修订版WHO诊断标准。
  • 研究队列可能不能代表新加坡产科总体人群,尽管参与者来自该国两家最大的产科医院并包括私人和补贴患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does IVF independently increase the risk of gestational diabetes mellitus (GDM) and is this increase in risk modified by maternal body mass index? SUMMARY ANSWER: IVF appears to be an independent risk factor for GDM and elevated blood glucose levels in overweight women (BMI > 25 kg/m2). WHAT IS KNOWN ALREADY: IVF has been associated with increased risk of GDM, but most previous studies did not adequately assess confounding or effect modification by other risk factors. STUDY DESIGN, SIZE, DURATION: Cross-sectional study using data from 1089 women with singleton pregnancies who participated in a Singaporean birth cohort study (GUSTO) and received a 75 g oral glucose tolerance test (OGTT) at 26-28 weeks gestation. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 1089 women (n = 1013 conceived spontaneously, n = 76 conceived through IVF) with singleton pregnancies received a 75 g OGTT at 26-28 weeks gestation. Fasting and 2 h postprandial blood glucose levels were assayed. World Health Organization criteria (1999) standard criteria were used to classify GDM: ≥7.0 mmol/L for fasting and/or ≥7.8 mmol/L for 2-h postprandial plasma glucose levels, which was the clinical guideline in use during the study. MAIN RESULTS AND THE ROLE OF CHANCE: IVF pregnancies had nearly double the odds of GDM (OR = 1.83, 95% CI: 1.03-3.26) and elevated fasting (mean difference = 0.12 mmol/L, 95% CI: 0.00-0.24) and OGTT 2-h blood glucose levels (mean difference = 0.64 mmol/L, 95% CI: 0.27-1.01), after adjusting for commonly recognized risk factors for GDM. After stratification by first-trimester BMI, these increased risks of GDM (OR = 3.54, 95% CI: 1.44-8.72) and elevated fasting (mean difference = 0.39 mmol/L, 95% CI: 0.13-0.65) and 2-h blood (mean difference = 1.24 mmol/L, 95% CI: 0.56-1.91) glucose levels were significant only in the IVF group who is also overweight or obese (BMI > 25 kg/m2). LIMITATIONS REASONS FOR CAUTION: One limitation of our study is the absence of a 1 h post-OGTT plasma glucose sample, as we were using the 1999 WHO diagnostic criteria (the clinical guideline in Singapore) at the time of our study, instead of the revised 2013 WHO diagnostic criteria. Our cohort may not be representative of the general Singapore obstetric population, although participants were recruited from the two largest maternity hospitals in the country and include both private and subsidized patients. WIDER IMPLICATIONS OF THE FINDINGS: IVF appears to be an independent risk factor for GDM and elevated blood glucose levels in overweight women. Our findings reinforce the need to advise overweight or obese women contemplating IVF to lose weight before the procedure to reduce their risk of GDM and hyperglycemia-related adverse outcomes arising therefrom. In settings where universal GDM screening is not routine, overweight or obese women who conceive by IVF should be screened. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Program and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore (NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014). Additional funding was provided by the Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR). K.M.G. and Y.S.C. have received lecture fees from Nestle Nutrition Institute and Danone, respectively. K.M.G., Y.S.C. and S.Y.C. are part of an academic consortium that has received research funding from Abbott Nutrition, Nestec and Danone. The other authors have nothing to disclose. The other authors have nothing to disclose. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Cai S, Natarajan P, Chan JKY, et al. Maternal hyperglycemia in singleton pregnancies conceived by IVF may be modified by first-trimester BMI. Hum Reprod. 2017. PMID: 28854717. doi:10.1093/humrep/dex243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。